研发费用率
Search documents
盛合晶微冲刺IPO 募资扩产引争议
Bei Jing Shang Bao· 2025-11-04 16:13
Core Viewpoint - Shenghe Jingwei Semiconductor Co., Ltd. is set to launch an IPO on the Sci-Tech Innovation Board, showcasing significant growth in performance, transitioning from a net loss in 2022 to a profit exceeding 400 million yuan in the first half of this year. However, the company exhibits a high dependency on its largest customer, which accounts for over 70% of its revenue, raising concerns about its revenue stability and bargaining power [1][3][4]. Group 1: Financial Performance - Shenghe Jingwei's revenue has shown explosive growth, with figures of approximately 16.33 billion yuan in 2022, 30.38 billion yuan in 2023, 47.05 billion yuan in 2024, and 31.78 billion yuan in the first half of 2024. Corresponding net profits were -3.29 billion yuan, 341.3 million yuan, 2.14 billion yuan, and 435 million yuan [3][4]. - The company's reliance on its top five customers has increased, with their combined sales revenue percentages being 72.83%, 87.97%, 89.48%, and 90.87% over the reporting periods. Specifically, the revenue from customer A constituted 40.56%, 68.91%, 73.45%, and 74.4% [3][4]. Group 2: Customer Dependency - The high customer concentration is a notable concern, as the semiconductor packaging industry is characterized by a few dominant players. Shenghe Jingwei has established long-term relationships with major clients, which may mitigate risks but also places the company in a vulnerable position if customer A faces operational issues [4][5]. - The company has signed long-term framework agreements with key clients, which aids in ensuring business stability and enhancing competitive advantages [4]. Group 3: Capacity Expansion Plans - Shenghe Jingwei plans to raise approximately 4.8 billion yuan for capacity expansion, with 4 billion yuan allocated to a 3D multi-chip integration packaging project and 800 million yuan for a high-density interconnect project [5][6]. - Despite the planned expansion, the company’s current capacity utilization rates have not reached saturation, with figures of 65.61%, 75.22%, 77.76%, and 79.09% for the years 2022 to 2024 and the first half of 2024 [6][7]. Group 4: Research and Development - The proportion of R&D personnel at Shenghe Jingwei has been declining, with figures of 18.13%, 14.11%, 13.77%, and 11.11% over the reporting periods, nearing the minimum requirement for the Sci-Tech Innovation Board [8][9]. - Although R&D expenditures have increased, the R&D expense ratio has decreased from 15.72% in 2022 to 11.53% in the first half of 2024, attributed to faster revenue growth compared to R&D spending [9]. Group 5: Corporate Governance - Shenghe Jingwei has a dispersed shareholding structure with no controlling shareholder, which may lead to challenges in decision-making due to differing interests among shareholders [9][10]. - The company asserts that it has established a clear and effective corporate governance structure to ensure efficient strategic decision-making and operational management [10].
研发费用率走低、与东岳集团关系复杂,未来材料闯关科创板
Bei Jing Shang Bao· 2025-10-22 13:56
Core Viewpoint - Shandong Dongyue Future Hydrogen Energy Materials Co., Ltd. (referred to as "Future Materials") is progressing with its IPO process despite a decline in revenue and net profit for 2024, although the downward trend has slowed in the first half of 2025 [1][4]. Financial Performance - Future Materials reported revenues of approximately 5.24 billion, 7.21 billion, 6.4 billion, and 3.49 billion for the years 2022, 2023, 2024, and the first half of 2025, respectively. Corresponding net profits were approximately 1.43 billion, 2.3 billion, 1.65 billion, and 926.69 million [4]. - The company's main business revenue accounted for over 95% of total revenue during the reporting period [4]. - The decline in revenue and net profit for 2024 is attributed to increased industry capacity and intensified competition affecting sales of key products [4]. Research and Development - Future Materials' R&D expenses were 602.95 million, 886.41 million, 610.74 million, and 310.07 million for the years 2022, 2023, 2024, and the first half of 2025, representing 11.51%, 12.29%, 9.54%, and 8.89% of revenue, respectively [6]. - Despite the decline in R&D expense ratio, the company maintained a higher level compared to industry peers, whose average R&D expense ratios were approximately 5.34%, 6.2%, 5.7%, and 5.24% during the same periods [6]. Customer and Supplier Relationships - Future Materials has a close capital relationship with Dongyue Group, with significant transactions occurring between the two entities [8]. - Dongyue Group's subsidiary, Dongyue Fluorosilicon, has been a major customer, accounting for 13.33%, 14.19%, 13.44%, and 15.44% of Future Materials' main business revenue from 2022 to 2025 [8][9]. - Dongyue Fluorosilicon also served as the primary supplier, with procurement amounts representing 43.69%, 31.8%, and 16.02% of total purchases during the reporting period [9]. Control and Independence - Future Materials underwent a change in control in 2022, with the current control held by Zhang Jianhong, who holds 35.5% of the voting rights [10]. - The company asserts its operational independence from Dongyue Group and Dongyue Fluorosilicon, with clear separations in business and production operations [10].
健信超导IPO上会 毛利率显著低于同行
Bei Jing Shang Bao· 2025-10-16 16:17
Core Viewpoint - The company, Ningbo Jianxin Superconducting Technology Co., Ltd., is preparing for its IPO on the Sci-Tech Innovation Board, with a reduced fundraising target of 775 million yuan due to the cancellation of a supplementary working capital project [1][5][6]. Group 1: Company Overview - Jianxin Superconducting is the largest independent supplier of superconducting magnets globally and ranks second among domestic companies in the MRI equipment superconducting magnet market share [3][4]. - The company specializes in the research, production, and sales of core components for medical MRI equipment, with superconducting magnets, permanent magnets, and gradient coils constituting about 50% of the MRI equipment's core component costs [3]. Group 2: Financial Performance - The company reported revenues of 359 million yuan, 451 million yuan, 425 million yuan, and 252 million yuan for the years 2022 to 2024 and the first half of 2025, respectively, with net profits of 34.63 million yuan, 48.73 million yuan, 55.78 million yuan, and 31.92 million yuan during the same periods [3]. - The company has maintained consistent cash dividends over the reporting period, with amounts around 19.99 million yuan each year from 2022 to 2024 [6]. Group 3: IPO Process and Fundraising - The IPO process has been relatively swift, with the company receiving acceptance on May 9 and entering the inquiry phase by May 31, undergoing two rounds of inquiries before the upcoming meeting on October 21 [3][4]. - The revised fundraising plan includes 275 million yuan for an annual production of 600 sets of non-liquid helium superconducting magnets, 260 million yuan for a technical upgrade project for high-field medical superconducting magnets, and 240 million yuan for new superconducting magnet research and development [5][6]. Group 4: Market Position and Growth Potential - The company is positioned to enhance its market share by integrating into the supply chains of leading complete machine enterprises, indicating significant growth potential in its product market share [4]. - The company aims to increase its R&D investment, expand production scale, and enhance its competitive advantage and profitability post-IPO [4]. Group 5: Financial Metrics and Industry Comparison - The company's gross margin has been significantly lower than the industry average, with figures of 19.56%, 22.84%, 24.94%, and 24.84% for the years 2022 to 2025, compared to industry averages of 46.27%, 45.59%, 45.17%, and 47.41% [8]. - The R&D expense ratio for the same periods was 5.66%, 5.42%, 6.5%, and 6.65%, indicating efficient use of R&D funds due to prior investments and technological accumulation [9].
3家公司IPO集中上会,优迅股份二度迎考
Bei Jing Shang Bao· 2025-10-13 13:30
Core Viewpoint - Three companies are scheduled for IPO hearings from October 13 to 17, with Beijing Angrui Microelectronics Technology Co., Ltd. and Xiamen Youxun Chip Co., Ltd. targeting the Sci-Tech Innovation Board, while Shenzhen Tiansu Measurement and Testing Co., Ltd. is aiming for the Growth Enterprise Market. Notably, Youxun Chip is making a second attempt after a previous delay in its review process. All three companies have R&D expense ratios below the industry average [1][4][8]. Group 1: IPO Details - The Shanghai Stock Exchange's listing review committee will review Youxun Chip and Angrui Micro on October 15, while the Shenzhen Stock Exchange will review Tiansu Measurement on October 16 [4]. - Angrui Micro plans to raise approximately 2.067 billion yuan, focusing on the development and industrialization of 5G RF front-end chips and related projects [4][5]. - Youxun Chip aims to raise about 809 million yuan for the development of next-generation access network chips and other projects [5][6]. - Tiansu Measurement plans to raise around 424 million yuan, the lowest among the three, for various projects including enhancing measurement capabilities [6]. Group 2: Financial Performance - Angrui Micro has not yet achieved profitability, with projected revenues of approximately 923 million yuan, 1.695 billion yuan, 2.101 billion yuan, and 844 million yuan for the years 2022 to 2025, respectively, and corresponding net losses [5]. - Youxun Chip's revenues for the same period are approximately 339 million yuan, 313 million yuan, 411 million yuan, and 238 million yuan, with net profits showing a positive trend [5]. - Tiansu Measurement's revenues are projected at approximately 597 million yuan, 726 million yuan, 800 million yuan, and 409 million yuan, with net profits also showing growth [6]. Group 3: R&D Expense Ratios - Angrui Micro's R&D expense ratios for 2022 to 2025 are 29.25%, 23.38%, 14.94%, and 16.4%, all below the industry average [8]. - Youxun Chip's R&D expense ratios are 21.14%, 21.09%, 19.1%, and 15.81%, also below the industry average [8]. - Tiansu Measurement's R&D expense ratios are significantly lower at 4.43%, 4.3%, 4.13%, and 4.2%, compared to the industry average [8]. Group 4: Concerns and Risks - The low R&D expense ratios of the three companies raise concerns about their long-term competitiveness and ability to innovate [9]. - Youxun Chip has faced scrutiny regarding its declining gross margins, which were 55.26%, 49.14%, 46.75%, and 43.48% over the reporting periods [10]. - The stability of Youxun Chip's actual controller's voting rights is also in question, as their control will decrease from 27.13% to 20.35% post-IPO [10].
新广益IPO过会 研发费用率低于同行的原因及合理性被追问
Bei Jing Shang Bao· 2025-09-19 19:54
Group 1 - The core viewpoint of the news is that Suzhou Xinguangyi Electronics Co., Ltd. has successfully passed the IPO review on the ChiNext board, aiming to raise approximately 638 million yuan for functional materials projects [1] - Xinguangyi focuses on the research, production, and sales of high-performance special functional materials, with main products including anti-overflow special films and strong resistance special films [1] - The company’s IPO was accepted on June 29, 2023, and entered the inquiry stage on July 25, 2023 [1] Group 2 - The listing committee requested Xinguangyi to explain the technical advantages of its main products and the sustainability of its operating performance, considering industry competition, core technology, downstream customer needs, and cost factors [1] - The committee also required an explanation of the background and contributions of core technical and R&D personnel, as well as the rationale behind the lower R&D expense ratio compared to industry peers [1] - Xinguangyi's R&D expense ratios for 2022-2024 are 4.9%, 5.35%, and 4.72%, which are significantly lower than those of peers like Fangbang Co. and Stik [2]
东盛金材IPO:今年上半年净利下滑超30% 研发费用率低于可比公司被关注
Sou Hu Cai Jing· 2025-09-15 09:52
Core Viewpoint - Dongsheng Jinmaterial's significant decline in operating performance in 2023 has drawn attention from the exchange, with a notable drop in both revenue and net profit reported in their latest financial disclosures [2][3][10]. Group 1: Financial Performance - In the first half of 2025, the company reported operating revenue of 367 million yuan, a year-on-year decrease of 0.35%, and a net profit attributable to shareholders of 2.021 million yuan, down 34.15% [13][15]. - The company's revenue from 2021 to the first half of 2025 shows a downward trend, with revenues of 9.30 billion yuan in 2021, 10.45 billion yuan in 2022, 6.58 billion yuan in 2023, and 3.68 billion yuan in the first half of 2025 [6][10]. - The net profit figures for the same period were 946.98 million yuan in 2021, 1.22 billion yuan in 2022, 517.59 million yuan in 2023, and 306.93 million yuan in the first half of 2025, indicating a significant decline in profitability [6][10]. Group 2: Business Operations - Dongsheng Jinmaterial specializes in the research, production, and sales of aluminum alloy element additives and other new metal functional materials, with approximately 90% of its revenue derived from aluminum alloy element additives [3][5]. - The company is one of the few globally capable of mass-producing aluminum alloy element additives with a metal content exceeding 95%, showcasing its technological leadership in the industry [3][5]. - The company faced inquiries regarding its performance fluctuations, low R&D investment, and supply chain risks, which were addressed in their responses to the exchange [5][10]. Group 3: R&D and Innovation - The company's R&D expenditure as a percentage of revenue was reported at 1.66% in 2023, which is lower than the 2%-5% range of comparable companies [16][20]. - Dongsheng Jinmaterial attributed its lower R&D spending to its unique industry characteristics and accounting practices, stating that costs related to trial products were not included in R&D expenses [20][21]. - The company plans to raise approximately 350 million yuan for projects including the production of alloy additives and the establishment of a research center [27][28].
优迅股份IPO隐忧:毛利水平“两连降”,研发费用率不及行业均值
Sou Hu Cai Jing· 2025-07-18 11:49
Core Viewpoint - Recently, Xiamen Youxun Chip Co., Ltd. (referred to as "Youxun") has changed its IPO review status to "inquired" on the Sci-Tech Innovation Board, with CITIC Securities as its sponsor [1] Group 1: Company Overview - Youxun was established in February 2003 and is one of the first companies in China specializing in the design of high-speed transceiver chips for optical communication [3] - The company has become a "national champion" in the optical communication field and has participated in the formulation of numerous national and industry standards [3] Group 2: Financial Performance - Youxun's revenue for 2022, 2023, and 2024 was 339.07 million, 313.13 million, and 410.56 million respectively, with a decline of 7.65% in 2023 [9] - The net profit for the same years was 81.40 million, 72.08 million, and 77.87 million, also showing a decrease of 8.02% in 2023 [9] - The company's R&D investment for 2022, 2023, and 2024 was 71.68 million, 66.05 million, and 78.43 million respectively, with a cumulative investment of 216 million over three years [6][7] Group 3: Market Position and Product Development - Youxun has established a complete core technology system in optical communication chip design, achieving breakthroughs in key areas such as transceiver integration and high-speed modulation [6] - The company has successfully entered the global supply chain and ranks first in China and second in the world for products with speeds below 10Gbps [6] - Youxun is actively developing high-value-added new products, including 50G PON transceiver chips and automotive optical communication chips [6] Group 4: R&D and Profitability - The R&D expense ratio for Youxun was 21.14%, 21.09%, and 19.10% for 2022, 2023, and 2024, significantly lower than the industry average of 31.65% and 31.45% [7][9] - The gross profit margin for the main business decreased from 55.26% in 2022 to 46.75% in 2024, indicating pressure from rising raw material costs and declining sales prices [13][14] Group 5: Supply Chain and Inventory Management - The average purchase price of wafers increased by approximately 40.19% from 6,815.70 yuan per piece in 2022 to 9,555.07 yuan in 2024 [15][16] - The company's inventory value at the end of each reporting period was 130 million, 90.36 million, and 175 million, accounting for 38.48%, 25.45%, and 32.55% of current assets respectively [19] Group 6: Ownership Structure - As of the IPO application, the founder and chairman, Ke Binglan, directly holds 10.92% of the shares, with a total of 15.51% when including indirect holdings [22] - The actual controller's voting rights may be diluted to 20.35% post-issuance, raising concerns about potential control changes [24]
埃泰克冲A背后:关联方奇瑞汽车贡献过半营收
Bei Jing Shang Bao· 2025-07-17 13:21
Core Viewpoint - Wuhu Aiteke Automotive Electronics Co., Ltd. (referred to as "Aiteke") is under scrutiny for its IPO process, with notable growth in performance but significant related party transactions, particularly with Chery Automobile, which accounted for over 50% of sales in 2024 [1][4][5]. Financial Performance - Aiteke's revenue and net profit have shown steady growth from 2022 to 2024, with revenues of approximately 2.174 billion, 3.008 billion, and 3.468 billion yuan, and net profits of about 91.75 million, 194 million, and 213 million yuan respectively [4][5]. - The company's accounts receivable have increased consistently, with balances of 745 million, 1.086 billion, and 1.227 billion yuan at the end of each reporting period, representing 34.26%, 36.11%, and 35.39% of total revenue [6]. Related Party Transactions - Aiteke's sales to related parties, primarily Chery Automobile, amounted to approximately 600 million, 1.064 billion, and 1.869 billion yuan from 2022 to 2024, constituting 27.6%, 35.36%, and 53.89% of total revenue [4][5]. - The company has a high concentration of sales among its top five customers, with sales proportions of 73.16%, 80.92%, and 84.38% from 2022 to 2024 [5]. Research and Development - Aiteke's R&D expense ratio is significantly lower than the industry average, with rates of approximately 5.83%, 5.07%, and 5.19% from 2022 to 2024, compared to industry averages of 9.94%, 10.7%, and 9.78% [9]. - The company attributes its lower R&D spending to its smaller revenue scale compared to industry peers and differences in customer structure and product categories [9]. IPO and Fundraising - Aiteke plans to raise approximately 1.5 billion yuan through its IPO, with funds allocated for various projects including the production of automotive electronics and the expansion of production bases [7][8]. - The company aims to enhance capacity and technical accumulation in line with industry trends through these investments [8].
兆芯集成:低毛利率与高研发投入拖累盈利表现 研发费用结构异于同业是否合理?
Xin Lang Zheng Quan· 2025-07-11 08:26
Core Viewpoint - Zhaoxin Integrated's IPO application has been accepted by the Shanghai Stock Exchange, aiming to raise 4.169 billion yuan for new processor development and R&D center projects [1] Group 1: Financial Performance - Zhaoxin Integrated has experienced significant financial pressure, with a total loss exceeding 2 billion yuan over three years due to high R&D costs and declining gross margins [1][8] - The company's gross margin has sharply decreased from 38.79% in 2022 to 15.40% in 2024, significantly lower than the industry average [4][6] - The company reported net losses of 7.27 billion yuan, 6.76 billion yuan, and 9.51 billion yuan over the past three years, totaling 23.54 billion yuan [8] Group 2: Customer Dependency - Zhaoxin Integrated relies heavily on a few major customers, with the top five customers accounting for 88.60% to 96.63% of sales from 2022 to 2024 [3] - The first major customer, China Electronics International, contributed over 50% of sales during the same period, indicating a high customer concentration risk [3] Group 3: Product Performance - The company's main products, the "Kaixian" and "Kaisheng" series, have shown strong growth, with revenue growth rates of 74.64% and 51.78% for the "Kaixian" series in 2023 and 2024, respectively [2] - The "Kaisheng" series server processors exhibited even higher growth rates of 289.01% and 547.63% in the same years, albeit from a low base [2] Group 4: R&D Investment - Zhaoxin Integrated's R&D expenses were 9.84 billion yuan, 9.88 billion yuan, and 8.13 billion yuan over the past three years, representing an exceptionally high R&D expense ratio of 289.50% to 91.44% [8] - The company has a lower proportion of employee compensation in its R&D expenses compared to peers, which may affect its long-term competitiveness [9][10]
科创板年内第三家!健信超导IPO胜算几何
Bei Jing Shang Bao· 2025-05-12 11:48
Core Viewpoint - Ningbo Jianxin Superconducting Technology Co., Ltd. has recently received acceptance for its IPO application on the Sci-Tech Innovation Board, with significant revenue dependence on its largest customer, Fujifilm Group, which is expected to contribute over 40% of the company's revenue in 2024 [1][3]. Revenue Dependence - The company relies heavily on its top five customers, with sales to these clients accounting for approximately 73.75%, 76.68%, and 79.62% of total revenue from 2022 to 2024 [3]. - Sales to Fujifilm Group specifically are projected to represent 34.2%, 44.2%, and 42.71% of total revenue for the years 2022, 2023, and 2024, respectively [3][4]. Financial Performance - Jianxin Superconducting's revenue for 2022, 2023, and 2024 is approximately CNY 359 million, CNY 451 million, and CNY 425 million, respectively, with net profits of CNY 34.63 million, CNY 48.73 million, and CNY 55.78 million [3]. - The company's gross profit margins are significantly lower than industry peers, with margins of 19.56%, 22.84%, and 24.94% compared to industry averages of 46.27%, 45.59%, and 45.17% for the same periods [4]. Inventory and Cash Dividends - The company has experienced a substantial increase in inventory, with values of approximately CNY 182 million, CNY 236 million, and CNY 319 million at the end of each reporting period [4]. - Jianxin Superconducting has distributed significant cash dividends prior to the IPO, with amounts of CNY 19.99 million each year from 2022 to 2024, representing 57.74%, 41.04%, and 35.85% of net profits, respectively [5]. R&D Investment - The company's R&D expense ratio is notably lower than that of comparable companies, with rates of 5.66%, 5.42%, and 6.5% against industry averages of 14.44%, 14.41%, and 18.36% [7]. - Jianxin Superconducting plans to increase R&D investment, with part of the IPO proceeds allocated for this purpose to support new product and technology development [7]. Ownership Structure - As of the signing of the prospectus, the controlling shareholder, Xu Jianyi, holds 41.51% of the company, with the actual controllers collectively holding 59.92% of the voting rights [6].